Pharmacologic management of urinary incontinence, voiding dysfunction, and overactive bladder

Obstet Gynecol Clin North Am. 2009 Sep;36(3):493-507. doi: 10.1016/j.ogc.2009.08.001.

Abstract

Most drugs used in the treatment of urinary incontinence and voiding dysfunction in women modulate neuromuscular transmission in the urethra and bladder. Pharmacotherapy is the mainstay of treatment for overactive bladder. Although several different antimuscarinic medications are available for the treatment of overactive bladder, most have similar efficacy and tolerability. Pharmacotherapy has a limited role in the management of stress incontinence and voiding dysfunction in women. Newer drugs that target different mechanisms of action are being developed for the treatment of urinary incontinence and voiding dysfunction in women.

MeSH terms

  • Aged
  • Female
  • Humans
  • Middle Aged
  • Muscarinic Antagonists / therapeutic use
  • Urinary Bladder, Overactive / drug therapy*
  • Urinary Bladder, Overactive / physiopathology
  • Urinary Incontinence / drug therapy
  • Urinary Incontinence / physiopathology
  • Urination Disorders / drug therapy*
  • Urination Disorders / physiopathology

Substances

  • Muscarinic Antagonists